Mark Miller
Chief Investor Relations Officer
Replay available
Encompass Health Corporation (NYSE: EHC) Q4 2025 earnings conference call, held 2026-02-06. Replay captured from the company's public earnings webcast.

Chief Investor Relations Officer
President and Chief Executive Officer
Analyst, KeyBank
Analyst, Mizuho Securities
Analyst, Barclays
Analyst, Deutsche Bank
Analyst, Bank of America
Analyst, Jefferies
Analyst, William Blair
Analyst, Stevens
Analyst, Raymond James
Analyst, Leering Partners
Good morning, ladies and gentlemen, welcome to today's encompass health 4th, quarter 2025 earnings conference call at this time. I would like to inform all participants that their lines will be in a listen only mode after the speaker's remarks. There will be a question and answer period. If you would like to ask a question during this time, please press star 1 on your telephone. You will be limited to 1 question and 1 follow up question. Just a reminder. Today's call is being recorded. And if you have any objections, you may disconnect at this time. I will now turn the call over to Mr. Mark Miller, Encompass Health's Chief Investor Relations Officer. Mark, please go ahead. Thank you, Operator, and good morning, everyone. Thank you for joining Encompass Health's fourth quarter 2025 earnings call. Before we begin, if you do not already have a copy, the fourth quarter earnings release supplemental information and related form 8K filed with the SEC are available on our website at encompasshealth.com. On page two of the supplemental information, you will find the safe harbor statements, which are also set forth in greater detail on the last page of the earnings release. During the call, we'll make forward-looking statements such as guidance and growth projections, which are subject to risks and uncertainties, many of which are beyond our control. certain risks and uncertainties like those relating to regulatory developments as well as volume, bad debt, and cost trends that could cause actual results to differ materially from our projections, estimates, and expectations are discussed in the company's SEC filings, including the earnings release and related Form 8K and the Form 10K for the year ended December 31, 2025 when filed. We encourage you to read them. Your caution n...